Poltreg S.A. (PTG.WA)
PLN 40.0
(-7.83%)
PLN 40.0
(-7.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 415 Thousand PLN | 400.0% |
| 2022 | 83 Thousand PLN | 8299900.0% |
| 2021 | 1.00 PLN | -99.98% |
| 2020 | 5000.00 PLN | 0.0% |
| 2019 | - PLN | -100.0% |
| 2018 | 1.00 PLN | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 542 Thousand PLN | 22.07% |
| 2024 Q1 | 444 Thousand PLN | 6.99% |
| 2023 Q1 | 113 Thousand PLN | 36.14% |
| 2023 FY | 415 Thousand PLN | 400.0% |
| 2023 Q2 | 301 Thousand PLN | 166.37% |
| 2023 Q4 | 415 Thousand PLN | -26.55% |
| 2023 Q3 | 565 Thousand PLN | 87.71% |
| 2022 Q2 | -3.87 Million PLN | -104.76% |
| 2022 Q1 | -1.89 Million PLN | -189100100.0% |
| 2022 Q3 | -5.59 Million PLN | -44.4% |
| 2022 FY | 83 Thousand PLN | 8299900.0% |
| 2022 Q4 | 83 Thousand PLN | 101.48% |
| 2021 Q1 | 5000.00 PLN | 0.0% |
| 2021 Q4 | 1.00 PLN | -99.98% |
| 2021 Q3 | 5000.00 PLN | 0.0% |
| 2021 FY | 1.00 PLN | -99.98% |
| 2021 Q2 | 5000.00 PLN | 0.0% |
| 2020 Q4 | 5000.00 PLN | 0.0% |
| 2020 FY | 5000.00 PLN | 0.0% |
| 2020 Q1 | - PLN | 0.0% |
| 2019 FY | - PLN | -100.0% |
| 2018 FY | 1.00 PLN | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bioceltix S.A. | 8617.89 PLN | -4715.564% |
| BIOTON S.A. | 117.91 Million PLN | 99.648% |
| Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
| Mabion S.A. | 6.84 Million PLN | 93.935% |
| Molecure S.A. | - PLN | -Infinity% |
| NanoGroup S.A. | 63.37 Thousand PLN | -554.801% |
| Pharmena S.A. | 445 Thousand PLN | 6.742% |
| Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 97.638% |
| Ryvu Therapeutics S.A. | 2.11 Million PLN | 80.406% |
| Synthaverse S.A. | 15.48 Million PLN | 97.32% |
| Urteste S.A. | 162 Thousand PLN | -156.173% |